Cargando…

Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study

BACKGROUND: The Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of <120 mm Hg compared with a SBP goal of <140 mm Hg. Our study aimed to assess the applicability of SPRINT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chao, Chen, Kangyu, Cornelius, Victoria, Tomeny, Ewan, Wang, Yang, Yang, Xiaowei, Yuan, Xiaodan, Qin, Rui, Yu, Dahai, Wu, Zhenqiang, Wang, Duolao, Chen, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971845/ https://www.ncbi.nlm.nih.gov/pubmed/33661907 http://dx.doi.org/10.1371/journal.pmed.1003515

Ejemplares similares

Eligibility of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Chinese Adults
por: Chen, Liping, et al.
Publicado: (2020)

Clinical benefit of systolic blood pressure within the target range among patients with or without diabetes mellitus: a propensity score-matched analysis of two randomized clinical trials
por: Li, Chao, et al.
Publicado: (2022)

Monotherapy treatment with chlorthalidone or amlodipine in the systolic blood pressure intervention trial (SPRINT)
por: Vakil, Deep, et al.
Publicado: (2021)

Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT)
por: Agarwal, Rajiv
Publicado: (2017)

Time to Clinical Benefit of Intensive Blood Pressure Lowering in Patients 60 Years and Older With Hypertension: A Secondary Analysis of Randomized Clinical Trials
por: Chen, Tao, et al.
Publicado: (2022)

Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT)
por: Kern, Kyle C., et al.
Publicado: (2023)

Comparison of Clinical Trial Changes in Primary Outcome and Reported Intervention Effect Size Between Trial Registration and Publication
por: Chen, Tao, et al.
Publicado: (2019)

Is Medication Adherence Predictive of Cardiovascular Outcomes and Blood Pressure Control? The Systolic Blood Pressure Intervention Trial (SPRINT)
por: Glasser, Stephen P, et al.
Publicado: (2021)

Lowering systolic blood pressure does not increase stroke risk: an analysis of the SPRINT and ACCORD trial data
por: O'Conor, Ellen C., et al.
Publicado: (2018)

Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Zang, Jiabin, et al.
Publicado: (2021)

Intensive blood pressure control in patients with a history of heart failure: the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Pareek, Manan, et al.
Publicado: (2021)

Intensive Systolic Blood Pressure Treatment Remodels Brain Perivascular Spaces: A Secondary Analysis of SPRINT
por: Kern, Kyle C., et al.
Publicado: (2023)

Joint Effect of Non-invasive Central Systolic Blood Pressure and Peripheral Systolic Blood Pressure on Incident Hypertension in a Chinese Community-based Population
por: Wang, Shixuan, et al.
Publicado: (2018)

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms
por: Lee, Dawn, et al.
Publicado: (2014)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
por: Huang, Chenxi, et al.
Publicado: (2017)

Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial
por: Still, Carolyn H, et al.
Publicado: (2018)

The Association between the Montreal Cognitive Assessment and Functional Activity Questionnaire in the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Still, Carolyn H, et al.
Publicado: (2018)

Cost of treatment support for multidrug-resistant tuberculosis using patient-centred approaches in Ethiopia: a model-based method
por: Rosu, Laura, et al.
Publicado: (2023)

Multicenter evaluation of TB-SPRINT 59-Plex Beamedex®: accuracy and cost analysis
por: Barcellos, Regina Bones, et al.
Publicado: (2019)

Systolic Blood Pressure Trajectories and the Progression of Arterial Stiffness in Chinese Adults
por: Liu, Run, et al.
Publicado: (2022)

Flexible Wireless Passive LC Pressure Sensor with Design Methodology and Cost-Effective Preparation
por: Sun, Zhuqi, et al.
Publicado: (2021)

Effect of premature birth on long-term systolic blood pressure variability in women
por: Shi, Linying, et al.
Publicado: (2018)

Similarities in Hypertension Status but Differences in Mortality Risk: A Comparison of 2017 ACC/AHA and 2018 Chinese Hypertension Guidelines
por: Chen, Kangyu, et al.
Publicado: (2022)

Generalisability and potential deaths averted from intensive blood pressure treatment among the elderly population in the US and China: A nationally representative cross-sectional study
por: Li, Chao, et al.
Publicado: (2023)

Impact of Elevated Systolic Blood Pressure Levels on Mortality and Life Expectancy in Southeast Chinese Residents
por: Feng, Wei, et al.
Publicado: (2021)

Longitudinal age-dependent effect on systolic blood pressure
por: Joubert, Bonnie R, et al.
Publicado: (2009)

Effect of Premeasurement Rest Time on Systolic Ankle Pressure
por: Chuter, Vivienne H., et al.
Publicado: (2013)

Time to Benefit of Sodium-Glucose Cotransporter-2 Inhibitors Among Patients With Heart Failure
por: Chen, KangYu, et al.
Publicado: (2023)

Hypertension Subtypes, Mortality Risk, and Differential Effects Between Two Hypertension Guidelines
por: Mai, Hui, et al.
Publicado: (2022)

Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study
por: Penaloza-Ramos, Maria Cristina, et al.
Publicado: (2016)

Associations of plasma homocysteine levels with peripheral systolic blood pressure and noninvasive central systolic blood pressure in a community-based Chinese population
por: Momin, Mohetaboer, et al.
Publicado: (2017)

Cost-effectiveness of a pressure ulcer quality collaborative
por: Makai, Peter, et al.
Publicado: (2010)

Cost-effective Alternative for Negative-pressure Wound Therapy
por: Kim, Jeff J., et al.
Publicado: (2017)

Shunt surgery in idiopathic normal pressure hydrocephalus is cost-effective—a cost utility analysis
por: Tullberg, Mats, et al.
Publicado: (2017)

Accuracy of cuff blood pressure and systolic blood pressure amplification
por: Bui, Tan V., et al.
Publicado: (2023)

Costs, cost-effectiveness, and context
por: Engle-Stone, Reina, et al.
Publicado: (2022)

Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study
por: Wang, Anxin, et al.
Publicado: (2016)

Recommendations from the COST action CA17116 (SPRINT) for the standardization of perinatal derivative preparation and in vitro testing
por: Janev, Aleksandar, et al.
Publicado: (2023)

The cost-effectiveness of pharmacist-physician collaborative care models vs usual care on time in target systolic blood pressure range in patients with hypertension: a payer perspective
por: Jay, Jessica S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h4dfng9cm8o9q9866vbe27kdvu